Validation of Self-Reported Smokeless Tobacco Use by Measurement of Serum Cotinine Concentration Among US Adults
Authors:
- Israel T. AgakuIAIsrael T. Agaku
- Brian A. KingBKBrian A. King
Open Access
- 13 August 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 180 (7) , 749-754
Abstract
Although investigators have assessed the relationship between self-reported cigarette smoking and biomarker levels, the validity of self-reported information on smokeless tobacco (SLT) use is uncertain. We used aggregated data from the 2003–2004, 2005–2006, 2007–2008, and 2009–2010 administrations of the National Health and Nutrition Examination Survey (NHANES) to compare self-reported SLT use with serum concentrations of cotinine, a metabolite of nicotine, among US adults aged ≥18 years. Receiver operating characteristic analysis was used to determine the optimal serum cotinine cutpoint for discriminating SLT users from nonusers of tobacco, and concordance analysis was used to compare self-reported SLT use with cotinine levels. Among the 30,298 adult respondents who completed the NHANES during 2003–2010, 418 reported having exclusively used SLT and no other type of tobacco (cigarettes, cigars, or pipes) during the past 5 days, while 23,457 reported not using any tobacco. The optimal cotinine cutpoint for discriminating SLT users from non–tobacco users was 3.0 ng/mL (sensitivity = 97.0%, specificity = 93.0%), which was comparable to a revised cutpoint recommended for identifying adult cigarette smokers. Concordance with cotinine was 96.4% and 93.7% for self-reported SLT use and tobacco nonuse, respectively. These findings indicate that self-reported SLT use among adults correlates highly with serum cotinine levels and that the optimal cutpoint for minimizing misclassification of self-reported use is a serum cotinine concentration of 3.0 ng/mL.Keywords
This publication has 32 references indexed in Scilit:
- Use of Conventional and Novel Smokeless Tobacco Products Among US AdolescentsPediatrics, 2013
- Biomarker Measurements of Concurrent Exposure to Multiple Environmental Chemicals and Chemical Classes in ChildrenJournal of Toxicology and Environmental Health, Part A, 2011
- Comparison of Urine Cotinine and the Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) and Their Ratio to Discriminate Active From Passive SmokingNicotine & Tobacco Research, 2011
- Self‐reported smoking habits and serum cotinine levels in women with placental abruptionActa Obstetricia et Gynecologica Scandinavica, 2010
- Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specificN-nitrosaminesTobacco Control, 2010
- Receptivity to Taboka and Camel Snus in a U.S. test marketNicotine & Tobacco Research, 2009
- Validity of Self-reported Smoking Using Urinary Cotinine among Vocational High School StudentsJournal of Preventive Medicine and Public Health, 2009
- Optimal Serum Cotinine Levels for Distinguishing Cigarette Smokers and Nonsmokers Within Different Racial/Ethnic Groups in the United States Between 1999 and 2004American Journal of Epidemiology, 2008
- Salivary cotinine concentration versus self-reported cigarette smoking: Three patterns of inconsistency in adolescenceNicotine & Tobacco Research, 2006
- Comparison of Self‐Reported Smoking and Urinary Cotinine Levels in a Rural Pregnant PopulationJournal of Obstetric, Gynecologic, & Neonatal Nursing, 2004